Correction: Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510854/
https://www.ncbi.nlm.nih.gov/pubmed/37730277
http://dx.doi.org/10.1136/jitc-2023-006802corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510854/
https://www.ncbi.nlm.nih.gov/pubmed/37730277
http://dx.doi.org/10.1136/jitc-2023-006802corr1

Ejemplares similares